Loss-of-function de novo mutations play an important role in severe human neural tube defects
暂无分享,去创建一个
Guy A Rouleau | Dan Spiegelman | G. Rouleau | A. Dionne‐Laporte | V. Désilets | P. Lemay | M. Guyot | Élizabeth Tremblay | D. Spiegelman | É. Henrion | O. Diallo | P. De Marco | E. Merello | C. Massicotte | J. Michaud | V. Capra | Z. Kibar | Jacques L Michaud | Zoha Kibar | Philippe Lemay | Ousmane Diallo | Christine Massicotte | Alexandre Dionne-Laporte | Valeria Capra | Patrizia De Marco | Elisa Merello | Marie-Claude Guyot | Élizabeth Tremblay | Édouard Henrion | Valérie Désilets | P. de Marco | Édouard Henrion | Ousmane Diallo | Alexandre Dionne‐Laporte
[1] J. Veltman,et al. De novo mutations in human genetic disease , 2012, Nature Reviews Genetics.
[2] Philippe Soriano,et al. Shroom, a PDZ Domain–Containing Actin-Binding Protein, Is Required for Neural Tube Morphogenesis in Mice , 1999, Cell.
[3] T. Ohlmann,et al. The role of the DEAD‐box RNA helicase DDX3 in mRNA metabolism , 2013, Wiley interdisciplinary reviews. RNA.
[4] Michael F. Walker,et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.
[5] J. Wallingford,et al. Shroom Induces Apical Constriction and Is Required for Hingepoint Formation during Neural Tube Closure , 2003, Current Biology.
[6] N. Greene,et al. Neural tube defects: recent advances, unsolved questions, and controversies , 2013, The Lancet Neurology.
[7] N. Greene,et al. Understanding the causes and prevention of neural tube defects: Insights from the splotch mouse model. , 2009, Birth defects research. Part A, Clinical and molecular teratology.
[8] Boris Yamrom,et al. The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.
[9] A. Bassuk,et al. Genetic basis of neural tube defects. , 2009, Seminars in pediatric neurology.
[10] X. Miao,et al. Genetic Variants in the Folate Pathway and the Risk of Neural Tube Defects: A Meta-Analysis of the Published Literature , 2013, PloS one.
[11] J. Belmont,et al. SHROOM3 is a novel candidate for heterotaxy identified by whole exome sequencing , 2011, Genome Biology.
[12] J. Kere,et al. Dominant mutations in GRHL3 cause Van der Woude Syndrome and disrupt oral periderm development. , 2014, American journal of human genetics.
[13] N. Greene,et al. Grainyhead genes and mammalian neural tube closure. , 2008, Birth defects research. Part A, Clinical and molecular teratology.
[14] Jessica R. Harrell,et al. Apical constriction: a cell shape change that can drive morphogenesis. , 2010, Developmental biology.
[15] M. Bouchard,et al. Maturation of ureter-bladder connection in mice is controlled by LAR family receptor protein tyrosine phosphatases. , 2009, The Journal of clinical investigation.
[16] Prevention of neural tube defects: Results of the Medical Research Council vitamin study , 1991 .
[17] Stephan J Sanders,et al. A framework for the interpretation of de novo mutation in human disease , 2014, Nature Genetics.
[18] Ulrich Stelzl,et al. Dynamic protein-protein interaction wiring of the human spliceosome. , 2012, Molecular cell.
[19] Two‐hit wonder: a novel genetic model to explain variable expressivity in severe pediatric phenotypes , 2010, Clinical genetics.
[20] M. Tassabehji,et al. A complete physical contig and partial transcript map of the Williams syndrome critical region. , 1999, Genomics.
[21] J. Gilbert,et al. Refinement of 2q and 7p loci in a large multiplex NTD family. , 2008, Birth defects research. Part A, Clinical and molecular teratology.
[22] M. Gnant,et al. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study , 1991, The Lancet.